PKM2 metabolic activator slows lung cancer xenograft growth

被引：0
|
作者：
Parnell, Mark [1 ]
Foulks, Jason M. [1 ]
Nix, Rebecca [1 ]
Luo, Bai [1 ]
Senina, Anna [1 ]
Xu, Yong [1 ]
Saunders, Michael [1 ]
Hol, Koc-Kan [1 ]
McCullar, Michael V. [1 ]
Kanner, Steven B. [1 ]
机构：
[1] Astex Pharmaceut Inc, Salt Lake City, UT USA
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-3226
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3226
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Germline loss of PKM2 promotes metabolic distress and hepatocellular carcinoma
    Dayton, Talya L.
    Gocheva, Vasilena
    Miller, Kathryn M.
    Israelsen, William J.
    Bhutkar, Arjun
    Clish, Clary B.
    Davidson, Shawn M.
    Luengo, Alba
    Bronson, Roderick T.
    Jacks, Tyler
    Vander Heiden, Matthew G.
    GENES & DEVELOPMENT, 2016, 30 (09) : 1020 - 1033
  • [32] Pyruvate kinase M2 (PKM2) in cancer and cancer therapeutics
    Zhu, Susi
    Guo, Yeye
    Zhang, Xu
    Liu, Hong
    Yin, Mingzhu
    Chen, Xiang
    Peng, Cong
    CANCER LETTERS, 2021, 503 : 240 - 248
  • [33] PKM2 regulates metabolic flux and oxidative stress in the murine heart
    Lee, Katie C. Y.
    Williams, Allison L.
    Wang, Lu
    Xie, Guoxiang
    Jia, Wei
    Fujimoto, Anastasia
    Gerschenson, Mariana
    Shohet, Ralph V.
    PHYSIOLOGICAL REPORTS, 2024, 12 (17):
  • [34] KAT8 enhances the resistance of lung cancer cells to cisplatin by acetylation of PKM2
    Li, Zhenyu
    Lu, Xiangji
    Zhang, Jing
    Liu, Tao
    Xu, Mingzhi
    Liu, Shuai
    Liang, Junguo
    ANTI-CANCER DRUGS, 2024, 35 (08) : 732 - 740
  • [35] Fasn Promote Non-Small-Cell Lung Cancer Growth And Chemoresistance By Upregulation Pkm2 And Enhancing Warburg Effect
    Jin, X.
    Huang, W.
    Wang, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [36] Activation of Akt protects cancer cells from growth inhibition induced by PKM2 knockdown
    Xiaodong Qin
    Yuping Du
    Xing Chen
    Wuyan Li
    Jinghong Zhang
    Jinbo Yang
    Cell & Bioscience, 4
  • [37] PKM2 is not required for colon cancer initiated by APC loss
    Allison N. Lau
    William J. Israelsen
    Jatin Roper
    Mark J. Sinnamon
    Larissa Georgeon
    Talya L. Dayton
    Alissandra L. Hillis
    Omer H. Yilmaz
    Dolores Di Vizio
    Kenneth E. Hung
    Matthew G. Vander Heiden
    Cancer & Metabolism, 5
  • [38] Recent Advances on PKM2 Inhibitors and Activators in Cancer Applications
    Chen, Peng
    Lou, Liang
    Sharma, Bigyan
    Li, Mengchu
    Xie, Chengliang
    Yang, Fen
    Wu, Yihang
    Xiao, Qicai
    Gao, Liqian
    CURRENT MEDICINAL CHEMISTRY, 2024, 31 (20) : 2955 - 2973
  • [39] Emerging Roles of ncRNAs Regulating PKM2 in Cancer Progression
    Xie, Haimei
    Yu, Jia
    Ou, Zhiwen
    Lei, Xiaoyong
    Yang, Xiaoyan
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2024,
  • [40] Metabolic reprogramming of myeloid cells with small molecule PKM2 activator MCTI-566 in the rd10 mouse
    Pan, Warren
    Weh, Eric
    Fernando, Roshini
    Chaudhury, Sraboni
    Subramanya, Shubha
    Miller, Nick
    Besirli, Cagri
    Wubben, Thomas
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
12345